As of 2024-12-12, the Relative Valuation of Avanos Medical Inc (AVNS) is 9.34 USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.69 USD, the upside of Avanos Medical Inc based on Relative Valuation is -50.0%.
The range of the Relative Valuation is 3.07 - 17.73 USD.
| Range | Selected | |
| Trailing P/E multiples | 33.6x - 51.9x | 43.2x |
| Forward P/E multiples | 27.0x - 39.4x | 34.5x |
| Fair Price | 3.07 - 17.73 | 9.34 |
| Upside | -83.6% - -5.1% | -50.0% |
| Date | P/E |
| 2024-12-11 | 55.03 |
| 2024-12-10 | 54.71 |
| 2024-12-09 | 54.27 |
| 2024-12-06 | 54.07 |
| 2024-12-05 | 55.30 |
| 2024-12-04 | 55.91 |
| 2024-12-03 | 55.71 |
| 2024-12-02 | 57.38 |
| 2024-11-29 | 56.09 |
| 2024-11-27 | 56.03 |
| 2024-11-26 | 56.09 |
| 2024-11-25 | 56.70 |
| 2024-11-22 | 54.45 |
| 2024-11-21 | 52.75 |
| 2024-11-20 | 52.31 |
| 2024-11-19 | 52.11 |
| 2024-11-18 | 53.04 |
| 2024-11-15 | 54.68 |
| 2024-11-14 | 56.06 |
| 2024-11-13 | 57.05 |
| 2024-11-12 | 58.26 |
| 2024-11-11 | 60.57 |
| 2024-11-08 | 59.75 |
| 2024-11-07 | 59.81 |
| 2024-11-06 | 61.33 |
| 2024-11-05 | 57.90 |
| 2024-11-04 | 56.24 |
| 2024-11-01 | 54.77 |
| 2024-10-31 | 54.68 |
| 2024-10-30 | 54.39 |
| 2024-10-29 | 66.25 |
| 2024-10-28 | 66.22 |
| 2024-10-25 | 65.40 |
| 2024-10-24 | 65.05 |
| 2024-10-23 | 65.49 |
| 2024-10-22 | 65.87 |
| 2024-10-21 | 66.95 |
| 2024-10-18 | 68.27 |
| 2024-10-17 | 69.12 |
| 2024-10-16 | 67.10 |
| 2024-10-15 | 66.74 |
| 2024-10-14 | 66.31 |
| 2024-10-11 | 66.07 |
| 2024-10-10 | 64.93 |
| 2024-10-09 | 65.75 |
| 2024-10-08 | 65.54 |
| 2024-10-07 | 66.10 |
| 2024-10-04 | 67.94 |
| 2024-10-03 | 67.39 |
| 2024-10-02 | 68.09 |